glp-1 list of drugs approved and pending medications Poll: 1 in 8 Adults
Description
Processing GLP-1 prescriptions for obesity often involves more complex interactions with insurers, including verification of coverage, handling of denials, and communication with prescribers
Reich, N
doi: 10.1523/JNEUROSCI.1799-17.2017 104 WuHYTangXQLiuHMaoXFWangYX
Patients receiving GLP-1 analogs sometimes saw significant weight loss, creating interest in using them as an obesity treatment
Retatrutide decreased HbA1c by 2.02% in a phase II clinical trial, while dulaglutide 1.5 mg decreased HbA1c by 1.14% and a placebo decreased it by 0.01% [109]
